Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

Published:2009-02 Issue:2 Volume:10 Page:147-156
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Coustan-Smith Elaine,Mullighan Charles G,Onciu Mihaela,Behm Frederick G,Raimondi Susana C,Pei Deqing,Cheng Cheng,Su Xiaoping,Rubnitz Jeffrey E,Basso Giuseppe,Biondi Andrea,Pui Ching-Hon,Downing James R,Campana Dario

Publisher

Elsevier BV

Subject

Oncology

Reference39 articles.

1. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience;Goldberg;J Clin Oncol,2003

2. Treatment of acute lymphoblastic leukemia;Pui;N Engl J Med,2006

3. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study;Pullen;Leukemia,1999

4. Prethymic phenotype and genotype of pre-T (CD7+/ER−)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia;Thiel;Blood,1989

5. Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia;Pui;Blood,1993

Cited by 803 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD133 in T‐lymphoblastic leukemia is preferentially expressed in early T‐phenotype (ETP) and near ETP subtypes;Cytometry Part B: Clinical Cytometry;2024-09-05

2. Blast phase of chronic myeloid leukemia presenting as early T-cell precursor acute lymphoblastic leukemia;American Journal of Clinical Pathology;2024-09-05

3. Fratricide-resistant CD7-CAR T cells in T-ALL;Nature Medicine;2024-09-03

4. CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia;2024-09-03

5. Clinicopathologic features and outcomes of acute leukemia harboring PICALM::MLLT10 fusion;Human Pathology;2024-09